Aims To estimate the association between patterns of anticholinergic, benzodiazepine and Z‐
drug medication use and change in cognitive function in middle‐aged and older adults …

Introduction: Muscarinic receptor antagonists, 5α-reductase inhibitors and α1-adrenoceptor
antagonists are frequently used drug classes for the treatment of lower urinary tract …

Objectives To investigate associations between central anticholinergic burden (determined
through the anticholinergic effect on cognition [AEC] scale) and mortality, hospitalisation and …

Objective To test the association between use of medicines with anticholinergic or sedative
properties and physical function, cognitive function, appetite and frailty. Design, setting and …

Objective This study aimed to explore the association between medication-associated
anticholinergic burden and cognitive and daily living functions in patients with …

Cognitive side effects of anticholinergic medications in older adults are well documented.
Whether these poor cognitive outcomes are observed in children has not been …

Background/objective (s) Psychotropic medications are commonly prescribed among adults
with intellectual disability, often in the absence of a psychiatric diagnosis. The aim of this …

Background Older adults purchase and use over-the-counter (OTC) medications with
potentially significant adverse effects. Some OTC medications, such as those with …

Introduction/Aim Anticholinergic drugs, which have severe central and peripheric side
effects, are frequently prescribed to older adults. Increased anticholinergic drug burden is …

Results: Altogether, 622 patients were included, 356 (57.2%) female, average age of 77.2
(±6.2), with an average of 5.6 medications. At least one anticholinergic medication was …